<DOC>
	<DOCNO>NCT01257126</DOCNO>
	<brief_summary>This local , phase IV , open-label , randomize , head head study child age 3 7 year . The objective study compare efficacy single dose diclofenac potassium nimesulide reduction fever pain secondary upper respiratory tract infection .</brief_summary>
	<brief_title>Efficacy Diclofenac Potassium v Nimesulide Treatment Fever Pain Children With Upper Respiratory Tract Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Nimesulide</mesh_term>
	<criteria>Children present community acquire , noncomplicated , upper respiratory tract infection : rhinosinusitis , pharyngitis , tonsillitis , ear infection combination . Child must present axillary temperature ≥ 37.5°C . Prior history allergic reaction component study medication . Use NSAID pharmacologic agent 24 hour prior visit 1 . Subjects , opinion investigator , develop , risk developing , complicate infection suitable subject purpose study . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Upper respiratory tract infection</keyword>
	<keyword>diclofenac potassium</keyword>
	<keyword>nimesulide</keyword>
	<keyword>fever</keyword>
	<keyword>pain</keyword>
</DOC>